SOPs for Nanoparticle Formulation

This SOP outlines the necessary ventilation and environmental controls in areas where nanoparticles are produced to minimize airborne nanoparticle exposure and ensure safe working conditions.
Click to read the full article.

This SOP outlines the procedures for safely managing and containing spills of nanoparticles in the laboratory or production environment, ensuring that exposure is minimized and that the spill is cleaned up effectively.
Click to read the full article.

This SOP outlines the procedure for lyophilizing nanoparticle-based formulations, which is used to improve the stability and shelf life of the nanoparticles by removing water through freeze-drying.
Click to read the full article.

This SOP outlines the procedure for incorporating cryoprotectants into nanoparticle formulations to preserve the stability and functionality of nanoparticles during freeze-drying (lyophilization) or cold storage.
Click to read the full article.

This SOP outlines the procedure for preparing liposomal nanoparticles, which are lipid-based vesicles used for drug delivery, encapsulating hydrophilic and hydrophobic drugs for targeted therapy.
Click to read the full article.

This SOP outlines the procedure for developing nanoparticle formulations intended for oral delivery, ensuring that the nanoparticles are stable in the gastrointestinal tract and can deliver the therapeutic agent effectively.
Click to read the full article.

This SOP outlines the procedure for synthesizing magnetic nanoparticles for biomedical applications, including targeted drug delivery, hyperthermia therapy, and MRI contrast enhancement.
Click to read the full article.

This SOP outlines the procedure for incorporating antioxidants into nanoparticle formulations to improve stability, reduce oxidative stress, and enhance the therapeutic effects of nanoparticles used in drug delivery or other biomedical applications.
Click to read the full article.

This SOP outlines the procedure for preparing nanoparticles intended for intravenous (IV) administration, focusing on producing nanoparticles with appropriate size, sterility, and biocompatibility for safe administration via the bloodstream.
Click to read the full article.

This SOP outlines the procedure for incorporating stabilizers into nanoparticle formulations to enhance the physical and chemical stability of the nanoparticles, preventing aggregation and degradation during storage and application.
Click to read the full article.